Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
522.00    2.00 (0.38%)
Bid:
518.00
Ask:
522.00
Spread: 4.00 (0.772%)
Market Cap: £863.73m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Director Dealing

13 Feb 2024 07:00

RNS Number : 8869C
Oakley Capital Investments Limited
13 February 2024
 

13 February 2024

 

Oakley Capital Investments Limited

 

Director Dealing

 

Oakley Capital Investments Limited1 (the "Company"), was notified today of the following transactions by a Director of the Company:

Peter Dubens, a Director of the Company, has purchased 151,160 Ordinary Shares of 1 pence each in the Company ("Ordinary Shares") at an aggregated price of 441 pence per share. As a result, Mr Dubens is now interested in 19,616,360 Ordinary Shares of the Company, representing 11.12 percent of the issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Peter Dubens

2

Reason for the notification

 

a)

Position/status

 

Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Oakley Capital Investments Limited

b)

LEI

 

213800KW6MZUK12CQ815

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 1p each

 

 

 

 

 

BMG670131058

b)

Nature of the transaction

 

Acquisition

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

436p

454p

 

 

110,660

40,500

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

151,160

 

 

441p

e)

Date of the transaction

 

9 and 12 February 2024

f)

Place of the transaction

 

London Stock Exchange, Specialist Fund Segment

 

 

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

 

Greenbrook Communications Limited

+44 20 7952 2000

Rob White / Michael Russell

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Chris Clarke / Darren Vickers / Owen Matthews

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds2.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/

The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V, Oakley Capital Origin Fund and Oakley Capital Origin II, are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

For more information on the Oakley Fund strategies in which OCI invests, please click here.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXLBFZLLFBBQ
Date   Source Headline
23rd Dec 20257:01 amRNSTransaction in Own Shares
23rd Dec 20257:01 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSOakley Capital invests in Athena Racing
23rd Dec 20257:00 amRNSOakley Capital invests in Athena Racing
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:09 amRNSOCI to participate in Time Out equity placing
18th Dec 20257:01 amRNSTransaction in Own Shares
17th Dec 20257:01 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSOakley Capital invests in James Perse
16th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:01 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSOakley Capital invests in Paraty Tech
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSDirector Dealing
3rd Nov 20257:01 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:01 amRNSAppointment of Chair Designate and NED
29th Oct 20257:00 amRNSQ3 Trading Update and Board Appointments
28th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSOakley Capital agrees sale of atHome
15th Oct 20257:01 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSOakley Capital invests in premium padel brand NOX
14th Oct 20257:00 amRNSOakley Capital invests in ONHC
1st Oct 20257:00 amRNSTotal Voting Rights
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20255:23 pmRNSDirector Dealing
16th Sep 20257:00 amRNSOakley renews commitment to K12 investments
11th Sep 20257:00 amRNSInterim Results for the 6 months ended 30 June 25
10th Sep 20257:00 amRNSResult of AGM - Replacement
2nd Sep 20252:20 pmRNSResult of AGM
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 202512:45 pmRNS-RQuotedData's In The HotSeat Special
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
21st Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSDirector Dealing
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSOakley granted exclusivity to invest in Brevo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.